DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images, regardless of their experience. LVivo IQS uses artificial intelligence (AI) to provide users with real-time feedback related to image quality. As the imaging…
Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial
Edited by Jonathon A. Leipsic Dr, Natalia Pinilla-Echeverri
Edited by Jonathon A. Leipsic Dr, Natalia Pinilla-Echeverri
Yet another large study finds that supplemental vitamin D and calcium aren’t helpful. Cancer deaths did go down, very slightly, but deaths from heart disease…
More than 5,000 U.S. physicians joined forces to launch the new group. They say they are focused on limiting private equity’s involvement and influence in…
More than 5,000 U.S. physicians joined forces to launch the new group. They say they are focused on limiting private equity’s involvement and influence in…
The rise of TAVR as a go-to treatment option for many AS patients has been one of the biggest stories in cardiology for several years…
Short of a definitive trial, MAG proponents make do with national registry data
Women would have to pay out-of-pocket, as reimbursement is a long way off
Researchers think this represents a potential breakthrough for low- and middle-income countries where access to high-quality imaging evaluations is still limited.
